A RAPID FLUORESCENCE BASED SCREEN FOR CYP51 INHIBITION

被引：0
|
作者：
Voice, Michael [1 ]
Macintyre, Gillian [1 ]
Pritchard, Michael [1 ]
机构：
[1] Cypex Ltd, Dundee, Scotland
来源：
DRUG METABOLISM AND PHARMACOKINETICS | 2020年 / 35卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P26
引用
收藏
页码：S29 / S29
页数：1
相关论文
共 50 条
  • [21] Structural basis for conservation in the CYP51 family
    Lepesheva, Galina I.
    Waterman, Michael R.
    BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2011, 1814 (01): : 88 - 93
  • [22] Potential anti-acanthamoebic effects through inhibition of CYP51 by novel quinazolinones
    Ahmed, Usman
    Ho, Keat-Yie
    Simon, Samson Eugin
    Saad, Syed Muhammad
    Ong, Seng-Kai
    Anwar, Areeba
    Tan, Kuan Onn
    Sridewi, Nanthini
    Khan, Khalid Mohammed
    Khan, Naveed Ahmed
    Anwar, Ayaz
    ACTA TROPICA, 2022, 231
  • [23] Differential inhibition of human CYP3A4 and Candida albicans CYP51 with azole antifungal agents
    Lamb, DC
    Kelly, DE
    Baldwin, BC
    Kelly, SL
    CHEMICO-BIOLOGICAL INTERACTIONS, 2000, 125 (03) : 165 - 175
  • [24] Dynamics of CYP51: implications for function and inhibitor design
    Yu, Xiaofeng
    Cojocaru, Vlad
    Mustafa, Ghulam
    Salo-Ahen, Outi M. H.
    Lepesheva, Galina I.
    Wade, Rebecca C.
    JOURNAL OF MOLECULAR RECOGNITION, 2015, 28 (02) : 59 - 73
  • [25] CYP51 azole sensitivity in lower vertebrates and invertebrate
    Morrison, AM
    Stegeman, JJ
    DRUG METABOLISM REVIEWS, 2003, 35 : 179 - 179
  • [26] CYP51 structure/function relationships in different phyla
    Waterman, MR
    Lepesheva, GI
    DRUG METABOLISM REVIEWS, 2002, 34 : 8 - 8
  • [27] Three-dimensional modeling of cytochrome P450 14α-demethylase (CYP51) and interaction of azole fungicide metconazole with CYP51
    Ito, A
    Sudo, K
    Kumazawa, S
    Kikuchi, M
    Chuman, H
    NEW DISCOVERIES IN AGROCHEMICALS, 2005, 892 : 142 - 150
  • [28] Cloning and characterization of CYP51 from Mycobacterium avium
    Pietila, Michael P.
    Vohra, Pawan K.
    Sanyal, Bharati
    Wengenack, Nancy L.
    Raghavakaimal, Sreekumar
    Thomas, Charles F., Jr.
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2006, 35 (02) : 236 - 242
  • [29] Characterization of Saccharomyces cerevisiae CYP51 and a CYP51 fusion protein with NADPH cytochrome P-450 oxidoreductase expressed in Escherichia coli
    Venkateswarlu, K
    Kelly, DE
    Kelly, SL
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (04) : 776 - 780
  • [30] Targeting CYP51 for drug design by the contributions of molecular modeling
    Rabelo, Vitor W.
    Santos, Taisa F.
    Terra, Luciana
    Santana, Marcos V.
    Castro, Helena C.
    Rodrigues, Carlos R.
    Abreu, Paula A.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2017, 31 (01) : 37 - 53
12345